Korean Journal of Radiology

  • 제21권8호
  • /
  • Pages.1007-1017
  • /
  • 2020
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

Development and Validation of a Prognostic Nomogram Based on Clinical and CT Features for Adverse Outcome Prediction in Patients with COVID-19

  • Yingyan Zheng (Department of Radiology, Huashan Hospital, Fudan University) ;
  • Anling Xiao (Department of Radiology, FuYang No.2 People's Hospital) ;
  • Xiangrong Yu (Department of Radiology, Zhuhai People's Hospital, Zhuhai Hospital affiliated with Jinan University) ;
  • Yajing Zhao (Department of Radiology, Huashan Hospital, Fudan University) ;
  • Yiping Lu (Department of Radiology, Huashan Hospital, Fudan University) ;
  • Xuanxuan Li (Department of Radiology, Huashan Hospital, Fudan University) ;
  • Nan Mei (Department of Radiology, Huashan Hospital, Fudan University) ;
  • Dejun She (Department of Radiology, Huashan Hospital, Fudan University) ;
  • Dongdong Wang (Department of Radiology, Huashan Hospital, Fudan University) ;
  • Daoying Geng (Department of Radiology, Huashan Hospital, Fudan University) ;
  • Bo Yin (Department of Radiology, Huashan Hospital, Fudan University)
  • 투고 : 2020.04.20
  • 심사 : 2020.05.20
  • 발행 : 2020.08.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: The purpose of our study was to investigate the predictive abilities of clinical and computed tomography (CT) features for outcome prediction in patients with coronavirus disease (COVID-19). Materials and Methods: The clinical and CT data of 238 patients with laboratory-confirmed COVID-19 in our two hospitals were retrospectively analyzed. One hundred sixty-six patients (103 males; age 43.8 ± 12.3 years) were allocated in the training cohort and 72 patients (38 males; age 45.1 ± 15.8 years) from another independent hospital were assigned in the validation cohort. The primary composite endpoint was admission to an intensive care unit, use of mechanical ventilation, or death. Univariate and multivariate Cox proportional hazard analyses were performed to identify independent predictors. A nomogram was constructed based on the combination of clinical and CT features, and its prognostic performance was externally tested in the validation group. The predictive value of the combined model was compared with models built on the clinical and radiological attributes alone. Results: Overall, 35 infected patients (21.1%) in the training cohort and 10 patients (13.9%) in the validation cohort experienced adverse outcomes. Underlying comorbidity (hazard ratio [HR], 3.35; 95% confidence interval [CI], 1.67-6.71; p < 0.001), lymphocyte count (HR, 0.12; 95% CI, 0.04-0.38; p < 0.001) and crazy-paving sign (HR, 2.15; 95% CI, 1.03-4.48; p = 0.042) were the independent factors. The nomogram displayed a concordance index (C-index) of 0.82 (95% CI, 0.76-0.88), and its prognostic value was confirmed in the validation cohort with a C-index of 0.89 (95% CI, 0.82-0.96). The combined model provided the best performance over the clinical or radiological model (p < 0.050). Conclusion: Underlying comorbidity, lymphocyte count and crazy-paving sign were independent predictors of adverse outcomes. The prognostic nomogram based on the combination of clinical and CT features could be a useful tool for predicting adverse outcomes of patients with COVID-19.

키워드

과제정보

The authors thank Zebin Xiao, at University of Pennsylvania, Philadelphia, US, for manuscript editing. We are also grateful to Weiwei Zheng, at Environmental Health, School of Public Health, Fudan University, Shanghai, China, and Dajun Tian, at Epidemiology and Biostatistics, College for Public Health and Social Justice, Saint Louis University, Saint Louis, Missouri, USA, for their assistance in statistical analyses.

참고문헌

  1. Coronavirus disease (COVID-19) pandemic. World Health Organization Web site. http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/novel-coronavirus-2019-ncov?SQ_VARIATION_428244=0/. Published January 7, 2020. Accessed March 24, 2020
  2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-733  https://doi.org/10.1056/NEJMoa2001017
  3. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382:1199-1207  https://doi.org/10.1056/NEJMoa2001316
  4. Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al.; Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536-544  https://doi.org/10.1038/s41564-020-0695-z
  5. Mahase E. Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ 2020;368:m641 
  6. National authorities. Coronavirus disease (COVID-19). Situation report-110. World Health Organization, 2020. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200509covid-19-sitrep-110.pdf?sfvrsn=3b92992c_4. Accessed May 10,
  7. Clinical management of severe acute respiratory infection when COVID-19 is suspected: interim guidance. World Health Organization Web site. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Published March 13, 2020. Accessed March 24, 2020 
  8. Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology 2020 Feb 21 [Epub]. https://doi.org/10.1148/radiol.2020200490 
  9. Zhao W, Zhong Z, Xie X, Yu Q, Liu J. CT scans of patients with 2019 novel coronavirus (COVID-19) pneumonia. Theranostics 2020;10:4606-4613  https://doi.org/10.7150/thno.45016
  10. Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology 2020;295:210-217  https://doi.org/10.1148/radiol.2020200274
  11. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-1720  https://doi.org/10.1056/NEJMoa2002032
  12. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008;246:697-722  https://doi.org/10.1148/radiol.2462070712
  13. Ooi GC, Khong PL, Muller NL, Yiu WC, Zhou LJ, Ho JCM, et al. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients. Radiology 2004;230:836-844  https://doi.org/10.1148/radiol.2303030853
  14. Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016;24:490-502  https://doi.org/10.1016/j.tim.2016.03.003
  15. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019;17:181-192  https://doi.org/10.1038/s41579-018-0118-9
  16. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-574  https://doi.org/10.1016/S0140-6736(20)30251-8
  17. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506  https://doi.org/10.1016/S0140-6736(20)30183-5
  18. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-513  https://doi.org/10.1016/S0140-6736(20)30211-7
  19. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020;55:2000547 
  20. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8:475-481  https://doi.org/10.1016/S2213-2600(20)30079-5
  21. Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol 2019;56:308-321  https://doi.org/10.1007/s12016-017-8648-x
  22. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061-1069  https://doi.org/10.1001/jama.2020.1585
  23. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020 Mar 13 [Epub]. https://doi.org/10.1001/jamainternmed.2020.0994 
  24. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology 2020 Feb 26 [Epub]. https://doi.org/10.1148/radiol.2020200642 
  25. Hosseiny M, Kooraki S, Gholamrezanezhad A, Reddy S, Myers L. Radiology perspective of coronavirus disease 2019 (COVID-19): lessons from severe acute respiratory syndrome and Middle East respiratory syndrome. AJR Am J Roentgenol 2020;214:1078-1082  https://doi.org/10.2214/AJR.20.22969
  26. Kumagai S, Arita M, Koyama T, Kumazawa T, Inoue D, Nakagawa A, et al. Prognostic significance of crazy paving ground grass opacities in non-HIV pneumocystis Jirovecii pneumonia: an observational cohort study. BMC Pulm Med 2019;19:47